Siflon Pharma Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 34.17 Cr
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 74.09 Cr
About Siflon Pharma
Siflon Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2022 (Two years and eight months 29 days old ). Its registered office is in Ananthapur, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 34.17 Cr.
The company currently has active open charges totaling ₹74.09 Cr.
The Key Managerial Personnel (KMP) at Siflon Pharma Private Limited India is Jatanghi Shilpa as COMPANY SECRETARY. Ananthaiah Rallapalli, Parvathi Rallapalli, and Swetha Rallapalli serve as directors at the Company.
Company Details
- Location
Ananthapur, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24200AP2022PTC121807
- Company No.
121807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Siflon Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ananthaiah Rallapalli  | Managing Director | 27-May-2022 | Current |
| Jatanghi Shilpa | Company Secretary | 02-Sep-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parvathi Rallapalli | Director | 27-May-2022 | Current |
| Swetha Rallapalli | Director | 27-May-2022 | Current |
Financial Performance of Siflon Pharma.
Siflon Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Siflon Pharma?
In 2023, Siflon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Siflon Polymers Private LimitedAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Drugs Private LimitedAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Greenvision Technologies Private LimitedJatanghi Shilpa is a mutual person
Charges (Loans)
₹74.09 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 64.34 Cr
- State Bank Of India : 9.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | State Bank Of India | ₹9.75 Cr | Open |
| 08 Dec 2023 | Axis Bank Limited | ₹64.34 Cr | Open |
How Many Employees Work at Siflon Pharma?
Siflon Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siflon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.